MedPath

Postoperative Intraperitoneal Pain Management Following Laparoscopic Cholecystectomy

Phase 3
Completed
Conditions
Post Operative Pain
Interventions
Registration Number
NCT06281418
Lead Sponsor
Future University in Egypt
Brief Summary

Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. No. study has investigated IP granisetron as an adjuvant to standard care for postoperative pain management in patients undergoing LC.

Detailed Description

Postoperative pain is a main challenge for delayed hospital discharge in Laparoscopic cholecystectomy. . Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. Granisetron is frequently used as a premedication to avoid postoperative nausea and vomiting in patients who have undergone general anesthesia. The purpose of this study is evaluating the efficacy and tolerability of IP granisetron on postoperative pain control in patients undergoing LC

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Patients who are scheduled to undergo elective LC.
  • Adults (males and/or females) between the ages of 18-70 years old.
Exclusion Criteria
  • Chronic pain other than cholelithiasis.
  • Patients who received analgesics or sedatives 24 h before scheduled surgery.
  • Severe hepatic (Child Pugh Class B and C) and renal dysfunction (CrCl <30ml/min)
  • Previous allergic response to granisetron.
  • Pregnancy and lactation
  • Patients with communication problems, cognitive dysfunction, or psychological disorders
  • Daily corticosteroid use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control armNormal saline2 ml IP normal saline (0.9 % NaCl)
Intervention armGranisetron 1 Mg/mL Intravenous Solution2ml IP granisetron (1 mg/mL)
Primary Outcome Measures
NameTimeMethod
VAS score2 hours, 4 hours, 8 hours, 12 hours, 24 hours

Pain intensity: VAS score

Secondary Outcome Measures
NameTimeMethod
Time to analgesic request24 hours

Time to first rescue analgesic request

Quality of life (QoL) after laparoscopic cholecystectomy (LC)3 months

Gastrointestinal Quality of Life Index questionnaire for QOL assessment with calculation of the score; most desirable option: 4 points, least desirable option: 0 points and GIQLI score: sum of the point. GIQLI ranges from 0 to 80 with higher scores indicating a better quality of life.

Trial Locations

Locations (1)

National Hepatology and Tropical Research Institute

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath